Skip to main content

Media Relations

Our Press and Media Relations team offers the latest press releases and background information on a variety of topics as well as image material for download.

Integrated diagnostic solutions for critical care settings

We are committed to improving patient outcomes with innovative diagnostic solutions for acute care that allow the diagnosis, outcome prediction, and monitoring of patients with acute medical conditions.

SphingoTec is a privately held company with its headquarters in Hennigsdorf near Berlin and with a wholly-owned subsidiary in San Diego, USA. With a long history of biomarker discovery, development, and validation, SphingoTec develops and markets innovative in vitro diagnostics solutions for its respective novel and proprietary blood-based protein biomarkers. 

Our aspiration is to effectively translate scientific advancements into routine clinical practice. We develop biomarkers addressing diagnostically underserved critical care conditions such as sepsis, acute heart failure, acute kidney injury, and cardiogenic shock. On the Nexus IB10 point-of-care analyzer, clinicians can deploy a wide range of commonly used parameters in acute and critical care settings, making the analyzer a useful addition to intensive care units (ICU), and emergency departments (ED), and other near-patient settings.

Subscribe to our Newsletter

Follow the link below to subscribe to our Newsletter & receive updates on our company and products

Subscribe now

Contact our Press & Media Relations Team

Ruxandra Lenz

Head of Marketing & Communications


Latest News

15. December 2022
SphingoTec announces first data on the kidney function biomarker penKid as a promising tool in supporting early initiation and liberation from RRT. Although RRT remains a pivotal measure in treating AKI complications, it is also associated with significant risks and its duration should be restricted to a minimum.
Read more
15. November 2022
Boditech Med Inc. and SphingoTec GmbH have entered into a non-exclusive royalty-bearing license agreement. Under the terms of this agreement, Boditech has obtained the rights to develop and commercialize clinical tests for the kidney function biomarker penKid on its renowned AFIAS and ichroma Point of Care platforms.
Read more
26. August 2022
Four units at the University Hospital Heidelberg and Heidelberg Kidney Center implement Proenkephalin (penKid) in a pilot biomarker-based treatment approach to diagnose AKI faster and monitor it more accurately across departments.
Read more

Media Coverage

15. November 2022
Boditech Med will develop and make point-of-care tests for acute kidney injury using a kidney function biomarker licensed from SphingoTec.
Read more
23. September 2022
Acute kidney injury (AKI) is a life-threatening disease that has no obvious symptoms in the early stages. Early identification of patients with AKI is one of the most critical unmet needs of physicians in their daily clinical practice. The focus of this article is on functional kidney biomarkers since it is not possible for damage markers to estimate the glomerular filtration rate (GFR).
Read more
18. August 2022
International medical leaders discussed the latest developments in diagnostic and therapeutic innovations for advancing precision medicine in critically ill patients.
Read more

Watch our upcoming and latest Webinars on demand

Find out about the latest breakthroughs in clinical diagnostics and get valuable insights from international healthcare experts. To improve patient management in critical care settings, we have created a series of webinars that look at the latest diagnostic innovations and how they influence today's clinical practice. Click here to see all available Webinars.


Using bio-ADM and penKid for optimization of AHF management in daily clinical practice

Speaker: Prof. John Parissis MD, PhD,  Attikon General Hospital


Using Proenkephalin as a Novel Biomarker to Estimate GFR

Speaker: Prof. Dr. Peter Pickkers, Radboud University, Nijmegen


Point-of-care Diagnostics in the Emergency Department: Better Patient Management

Speaker: Prof. Salvatore Di Somma, MD PhD; University La Sapienza Rome

Press photos for download